<![CDATA[Chronic kidney disease (CKD) is a major global health problem. In 2020, approximately 2.5 million people worldwide underwent hemodialysis. Comprehensive management, including a biopsychosocial approach, is required for patients with CKD undergoing hemodialysis. Depression and anxiety are common comorbid conditions among patients with CKD, with an estimated prevalence of approximately 25% in this population. The Hospital Anxiety and Depression Scale (HADS) questionnaire is widely used to assess anxiety and depression in patients with various medical conditions and has been proven to be a valid instrument for use in the general population. This study was a cross-sectional study aimed at describing the characteristics of anxiety and depression among hemodialysis patients at RSUD Buleleng. Among the 94 subjects, 65% were men, and most had anemia (94%). Only 36.17% had a high level of education. Based on HADS assessment results, 17.04% had mild anxiety, 1.06% had moderate anxiety, and 81.9% had no anxiety. The HADS assessment for depression showed that 12.76% had mild depression, 2.14% had moderate depression, and 85.1% had no depression.]]>
Copyrights © 2026
